SUBLINOX

Identification of Sublinox:

No description

Search images on Google      Product Monograph

Active Ingredients:

DIN: 02391678

Dosage Form(s): TABLET (ORALLY DISINTEGRATING)

Route(s) of Administration: SUBLINGUAL

Schedule: Targeted (CDSA IV)

Company: BAUSCH HEALTH, CANADA INC.

ATC:

Reference brand drug: Sublinox

Packaging:

  • Package size unit: No information
  • Package type: No information
  • Package size: No information
  • Product information: 10/30/100

 

External Links for Sublinox:

Search on Google